NZ332897A - Methods and compositions for modulating production of a T helper type 2 (Th2)-associated cytokine by regulating transcription factor activity in association with a Nuclear Factor of Activated T cells (NF-AT) protein - Google Patents
Methods and compositions for modulating production of a T helper type 2 (Th2)-associated cytokine by regulating transcription factor activity in association with a Nuclear Factor of Activated T cells (NF-AT) proteinInfo
- Publication number
- NZ332897A NZ332897A NZ332897A NZ33289797A NZ332897A NZ 332897 A NZ332897 A NZ 332897A NZ 332897 A NZ332897 A NZ 332897A NZ 33289797 A NZ33289797 A NZ 33289797A NZ 332897 A NZ332897 A NZ 332897A
- Authority
- NZ
- New Zealand
- Prior art keywords
- nip45
- protein
- methods
- maf
- activity
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108090000695 Cytokines Proteins 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 102000004127 Cytokines Human genes 0.000 title abstract 2
- 230000010632 Transcription Factor Activity Effects 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 101000573401 Homo sapiens NFATC2-interacting protein Proteins 0.000 abstract 8
- 102100026380 NFATC2-interacting protein Human genes 0.000 abstract 8
- 230000000694 effects Effects 0.000 abstract 5
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 102000007307 Maf Transcription Factors Human genes 0.000 abstract 2
- 108010033714 Maf Transcription Factors Proteins 0.000 abstract 2
- 102000039538 Maf family Human genes 0.000 abstract 2
- 108091067370 Maf family Proteins 0.000 abstract 2
- 239000013604 expression vector Substances 0.000 abstract 2
- 102000004388 Interleukin-4 Human genes 0.000 abstract 1
- 108090000978 Interleukin-4 Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 102000002673 NFATC Transcription Factors Human genes 0.000 abstract 1
- 108010018525 NFATC Transcription Factors Proteins 0.000 abstract 1
- 102000007987 Proto-Oncogene Proteins c-maf Human genes 0.000 abstract 1
- 108010089507 Proto-Oncogene Proteins c-maf Proteins 0.000 abstract 1
- 102000040945 Transcription factor Human genes 0.000 abstract 1
- 108091023040 Transcription factor Proteins 0.000 abstract 1
- 108700019146 Transgenes Proteins 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 229940028885 interleukin-4 Drugs 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5406—IL-4
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Environmental Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/636,602 US5958671A (en) | 1996-04-23 | 1996-04-23 | Methods and compositions for regulating T cell subsets by modulating transcription factor activity |
| US08/755,584 US5858711A (en) | 1996-11-25 | 1996-11-25 | NF-AT-interacting protein NIP45 and methods of use therefor |
| US08/755,592 US6537810B1 (en) | 1996-04-23 | 1996-11-25 | Methods for regulating T cell subsets by modulating transcription factor activity |
| PCT/US1997/006708 WO1997039721A2 (fr) | 1996-04-23 | 1997-04-23 | Procedes et compositions pour la regulation de sous-ensembles de lymphocytes t par la modulation de l'activite du facteur de transcription |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ332897A true NZ332897A (en) | 2000-04-28 |
Family
ID=27417596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ332897A NZ332897A (en) | 1996-04-23 | 1997-04-23 | Methods and compositions for modulating production of a T helper type 2 (Th2)-associated cytokine by regulating transcription factor activity in association with a Nuclear Factor of Activated T cells (NF-AT) protein |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0891425A2 (fr) |
| JP (1) | JP2000510333A (fr) |
| KR (1) | KR20000010606A (fr) |
| CN (1) | CN1225682A (fr) |
| AU (1) | AU720455B2 (fr) |
| CA (1) | CA2252643A1 (fr) |
| NZ (1) | NZ332897A (fr) |
| WO (1) | WO1997039721A2 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9722388D0 (en) * | 1997-10-24 | 1997-12-24 | Zeneca Ltd | NIP45 human homolog |
| US6274338B1 (en) | 1998-02-24 | 2001-08-14 | President And Fellows Of Harvard College | Human c-Maf compositions and methods of use thereof |
| US6548734B1 (en) | 1998-05-28 | 2003-04-15 | President And Fellows Of Harvard College | Methods relating to modulation of cartilage cell growth and/or differentiation by modulation of NFATp activity |
| ES2283340T3 (es) * | 1999-12-30 | 2007-11-01 | President And Fellows Of Harvard College | Metodos referentes a la modulacion de la actividad del subconjunto de celulas th2 mediante modulacion de la actividad de xbp-1. |
| CA2394831A1 (fr) * | 2000-01-11 | 2001-07-19 | Maxygen, Inc. | Sous-ensembles de cellules dendritiques derivees de monocytes |
| ATE340261T1 (de) * | 2000-04-25 | 2006-10-15 | Bayer Healthcare Ag | Regulation einer nf-at interagierenden proteinvariante nip 45 |
| WO2002029403A1 (fr) * | 2000-10-02 | 2002-04-11 | Mochida Pharmaceutical Co., Ltd. | Inhibiteur de l'expression de gata-3 et procede de depistage dudit inhibiteur |
| EP2135611A1 (fr) | 2001-03-01 | 2009-12-23 | Hollis-Eden Pharmaceuticals Inc. | Derivés de Pregn-5-en-20-yn-3,7,17-triol pour utilisation thérapeutique |
| US20050079496A1 (en) * | 2001-08-17 | 2005-04-14 | Edgar Serfling | Methods for diagnosing and treating neoplasias using nf-at transcriptions factors |
| IL147138A0 (en) | 2001-12-17 | 2002-08-14 | Yeda Res & Dev | Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation |
| EP1989544B1 (fr) * | 2006-03-02 | 2011-06-22 | Antitope Limited | Dosages de lymphocytes t |
| US8940479B2 (en) | 2008-01-14 | 2015-01-27 | Cornell University | Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity |
| KR101146335B1 (ko) * | 2009-10-12 | 2012-05-21 | 한국원자력의학원 | 알파태아단백 인헨서 및 프로모터의 조절을 받아 리포터 단백질을 발현하는 형질 전환 마우스, 그의 제조 방법 및 이를 이용한 알파태아단백 발현의 증가 또는 감소 유도 물질을 스크리닝하는 방법 |
| WO2012109238A2 (fr) | 2011-02-07 | 2012-08-16 | President And Fellows Of Harvard College | Procédés d'augmentation des réponses immunitaires à l'aide d'agents qui se lient directement à ire-1 et activent ire-1 |
| WO2013134774A1 (fr) | 2012-03-09 | 2013-09-12 | Cornell University | Modulation de la croissance du cancer du sein par modulation de l'activité de la xbp1 |
| WO2015019125A1 (fr) * | 2013-08-05 | 2015-02-12 | Societe De Developpement Et De Recherche Industrielle | Cibles moléculaires destinées au traitement des blessures, en particulier des blessures chroniques |
| DK3049521T3 (en) | 2013-09-25 | 2019-04-23 | Univ Cornell | Compounds for inducing antitumor immunity and methods thereof |
-
1997
- 1997-04-23 CN CN97195740A patent/CN1225682A/zh active Pending
- 1997-04-23 WO PCT/US1997/006708 patent/WO1997039721A2/fr not_active Application Discontinuation
- 1997-04-23 KR KR1019980708492A patent/KR20000010606A/ko not_active Application Discontinuation
- 1997-04-23 NZ NZ332897A patent/NZ332897A/xx unknown
- 1997-04-23 CA CA002252643A patent/CA2252643A1/fr not_active Abandoned
- 1997-04-23 EP EP97926377A patent/EP0891425A2/fr not_active Withdrawn
- 1997-04-23 JP JP09538278A patent/JP2000510333A/ja not_active Ceased
- 1997-04-23 AU AU31155/97A patent/AU720455B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000510333A (ja) | 2000-08-15 |
| AU720455B2 (en) | 2000-06-01 |
| CA2252643A1 (fr) | 1997-10-30 |
| WO1997039721A2 (fr) | 1997-10-30 |
| AU3115597A (en) | 1997-11-12 |
| EP0891425A2 (fr) | 1999-01-20 |
| CN1225682A (zh) | 1999-08-11 |
| WO1997039721A3 (fr) | 1998-04-09 |
| KR20000010606A (ko) | 2000-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ332897A (en) | Methods and compositions for modulating production of a T helper type 2 (Th2)-associated cytokine by regulating transcription factor activity in association with a Nuclear Factor of Activated T cells (NF-AT) protein | |
| DK0941318T3 (da) | Håndvægtformede konstruerede ekspressionssystemer til genterapi | |
| CA2165162A1 (fr) | Regulation etroite de l'expression de genes dans les cellules d'eucaryotes, grace a des promoteurs sensibles a la tetracycline | |
| AU7599500A (en) | Novel gl50 molecules and uses therefor | |
| WO1999043808A8 (fr) | Compositions de c-maf humaine et leurs methodes d'utilisation | |
| EP1798239A3 (fr) | Récepteurs de protéine G-couplés et utilisations correspondantes | |
| AP1678A (en) | Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems. | |
| AP9901542A0 (en) | DNA encoding lepidopteran-active delta-endotoxins and its use. | |
| WO2001073060A3 (fr) | 18221, nouveau phosphatase a specificite double et ses utilisations | |
| ATE352561T1 (de) | Pgc-1, ein neuartiger ppar-gamma-koaktivator aus braunem fettgewebe | |
| DE60144021D1 (de) | Für zellzyklusproteine kodierende nukleinsäure und deren verwendung | |
| WO1999047686A3 (fr) | Proteines humaines mekk, molecules d'acides nucleiques et procedes d'utilisation correspondants | |
| AU2002211446A1 (en) | 32144, a human fatty acid amide hydrolase and uses thereof | |
| DK1183355T3 (da) | T-BET-præparater og fremgangsmåder til fremstilling heraf | |
| EP1412374A4 (fr) | Nouveaux isoformes de pgc-1 et applications de ceux-ci | |
| NO20012471L (no) | Kaliumkanal-interaktorer og anvendelser derav | |
| WO2001075121A3 (fr) | 16836, un nouvel element de la famille de la phospholipase c humaine et ses utilisations | |
| MXPA03002557A (es) | Interactores de canales del potasio y sus usos. | |
| WO2001068857A3 (fr) | 18615 et 48003, nouveaux canaux ioniques humains, et utilisation associee | |
| WO2001075076A3 (fr) | 33167, nouvelle hydrolase humaine, et utilisations associees | |
| AU2001253258A1 (en) | Human trp-like calcium channel protein-2 (tlcc-2) | |
| ATA282386A (de) | Verfahren zur expression von genen in hefe und dna-fragmente und diese dna-fragmente enthaltende plasmide zur verwendung bei diesem verfahren | |
| AU2002234132A1 (en) | 13245, a novel human myotonic dystrophy type protein kinase and uses therefor | |
| WO2002044358A3 (fr) | Procédés et compositions se rapportant au diagnostic et au traitement du cancer par utilisation de 27420 | |
| WO2002006485A3 (fr) | 47885, une nouvelle enzyme activant l'ubiquitine humaine et ses applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) |